J.Jpn. Surg. Soc.. 86(9): 1212-1215, 1985
Report on the annual meeting
CURRENT PROBLEMS IN THE SURGICAL TREATMENT OF ACQUIRED HEART DISEASE
|
The 2nd Department of Surgery, Nihon University School of Medicine, Tokyo, Japan Shinzo Kitamura, Akira Miyamoto, Shoji Shindo, Kenji Akiyama, Motomi Shiono, Yukiyasu Sezai |
Early mortality rate of combined valvular and coronary artery surgery was 26%, and late mortality 21%, however, only 3 cases (15.8%) died of LOS. Mortality rate of combined coronary artery and peripheral vascular surgery was 43%, however 1 patient died of LOS. Mortality rate of TVR with SJM was 15% which was rather low in comparison with other valves.
A patient who underwent simultaneous surgical treatment of valvular or peripheral vascular disease, and coronary artery disease, ran almost the same risk of LOS as patients without ischemic heart disease. However, myocardial protection was important for these patients because of severe LV dysfunction and myocardial hypertrophy. There is not yet an ideal artificial valve for TVR. At present, SJM is the best available valve in terms of design and hemodynamics.
To read the PDF file you will need Adobe Reader installed on your computer.